By ending subsidies to standalone prescription drug plans, it’s expected they will have to raise premiums for at least 11 million Medicare beneficiaries.
Medicare patients are getting access to GLP-1s for obesity through the Bridge program. But questions linger regarding eligibility criteria, prior authorization and costs.
In the majority of states that don’t cover GLP-1s, Medicaid enrollees can pay out-of-pocket through the president’s ...
Confused about the Medicare Part D subsidy program? Here's which program is ending after 2026 and what it could mean for costs.
The Medicare Part D Premium Stabilization Demonstration will end on Dec. 31 and will not continue into 2027.
The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and ...
As discussed in last week’s Regs & Eggs blog post, the US Department of Health and Human Services (HHS) recently released additional budget documents to support the department’s fiscal year (FY) 2026 ...
The Trump administration is proposing sweeping changes to Medicare payment and value-based care programs that it says will expand accountable care, modernize physician payment, and help shift the ...
The Trump administration will end a subsidy program, meant to keep premiums stable for Medicare prescription drug plans, after 2026, the Centers for Medicare & Medicaid Services said on Tuesday.
The Trump administration has rejected Arkansas’ request to renew its hybrid Medicaid expansion, Gov. Sarah Huckabee Sanders’ office said Friday, creating uncertainty about the future of a program ...
A countdown clock is ticking on healthcare for thousands of Georgians, as the state’s Medicaid alternative could disappear by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results